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Underhill and colleagues (Shimada et al., 2010) provide evidence for an intriguing link between the activity of
lysozyme in the phagosome and activation of the Nlrp3 inflammasome, a cytosolic regulator of inflammation
and cytokine production. The authors show that resistance to lysozyme allows Staphylococcus aureus to
evade Nlrp3 activation.Staphylococcus aureus is a fascinating
microbe and one with a split personality.
On one hand, it is extremely dangerous,
with estimates suggesting certain methi-
cillin-resistant strains of S. aureus now
kill more Americans every year than HIV.
On the other hand, S. aureus colonizes
a substantial fraction (>20%) of Ameri-
cans without causing any symptoms at
all. What decides which personality pre-
dominates? No one really knows, but it
is clear that the success of S. aureus as
a commensal or as a pathogen involves
a delicate teˆte-a`-teˆte with the immune
system of its hosts. In this issue of Cell
Host & Microbe, Underhill and colleagues
(Shimada et al., 2010) describe how resis-
tance to lysozyme allows S. aureus to
avoid recognition by the Nlrp3 inflamma-
some, a cytosol-localized component of
the host innate immune system involved
in production of the potent inflammatory
cytokine IL-1b. Their results provide
support for the emerging idea that the
action of digestive enzymes in the phago-
some is linked to activation of immune
sensors in the cytosol.
IL-1b is a key regulator of inflammatory
responses to S. aureus, and mice defi-
cient in the ability to make or respond to
IL-1b exhibit increased susceptibility to
S. aureus infection (Miller et al., 2007).
However, the molecular mechanisms by
which IL-1b is produced in response to
S. aureus are still not fully resolved (Maria-
thasan et al., 2006; Mun˜oz-Planillo et al.,
2009). In general, IL-1b is produced in
a two-step process that first involves
production of a pro-IL-1b protein, typi-
cally in response to Toll-like receptor
stimulation. In a second step, pro-IL-1b
is then processed by a cysteine pro-tease, caspase-1, to yield the active and
secreted IL-1b cytokine.
Activation of caspase-1 is itself con-
trolled by a small family of multiprotein
complexes called ‘‘inflammasomes,’’
which reside in the cytosol and respond
to a variety of infectious or noxious
stimuli. In the past few years, several
distinct inflammasomes have been
described. For example, inflammasomes
containing the proteins Naip5 and Ipaf
activate caspase-1 in response to the
cytosolic presence of the bacterial protein
flagellin. A distinct inflammasome con-
taining the Aim2 protein responds to
cytosolic DNA. The most studied but still
poorly understood inflammasome con-
tains the Nlrp3 protein and responds to
a dizzying number of different stimuli,
including extracellular ATP, pore-forming
toxins, alum adjuvant, uric acid crystals,
silica, asbestos, and b-amyloid. Given
the structural diversity of stimuli that
activate the Nlrp3 inflammasome, it is
widely believed that these stimuli are
not direct ligands for Nlrp3, but are
instead provoking a more limited set of
proximal signals that are the true activa-
tors of Nlrp3. It is noteworthy that many
of the activators of Nlrp3 are crystalline
or crystal-like substances. It has been
suggested that phagocytosis of crystal-
line material results in disregulated pro-
duction of reactive oxygen intermediates
(ROI) (Dostert et al., 2008) and/or phago-
some rupture (Hornung et al., 2008), either
of which result in cytosolic damage that
could be sensed by Nlrp3.
Atwo-stepprocessfor IL-bproduction is
believed to provide a safeguard against
the unnecessary and potentially danger-
ous production of IL-1b. Release of activeCell Host & MicrobeIL-1b is reserved for scenarios in which
both a Toll-like receptor signal and a
distinct cytosolic signal are present. Al-
though harmless commensal bacteria may
stimulate the former, cytosolic invasion or
disruption is believed to be a ‘‘pattern of
pathogenesis’’ that arises only upon infec-
tion with pathogens (Vance et al., 2009).
In their study (Shimada et al., 2010),
Underhill and colleagues began with a
reductionist approach and treated macro-
phages with purified S. aureus peptido-
glycan (PGN). This treatment resulted in
significant IL-1b release after 18 hr of
stimulation. Although their PGN prepara-
tion appeared to contain contaminants
that could activate TLR2, leading to
production of pro-IL-1b, it was somewhat
unexpected that processed and active
IL-1b was secreted by treatment with
PGN alone. The ability of PGN to elicit
mature IL-1b secretion required Nlrp3
but did not require a known PGN sensor,
Nod2. A core constituent of PGN, mur-
amyl dipeptide (MDP), has been reported
to induce IL-1b production via Nlrp3, but
in most scenarios, MDP appears only to
act in conjunction with other bona fide
Nlrp3 stimuli (e.g., extracellular ATP) to
induce maturation and release of IL-1b.
Indeed, Shimada et al. observed that
MDP was not able to activate release of
mature IL-1b, either alone or in combina-
tion with TLR2 ligands, raising the ques-
tion of what rendered the S. aureus PGN
preparation stimulatory that was not reca-
pitulated by pure MDP.
Unlike MDP, PGN is a highly cross-
linked insoluble polymer. Shimada et al.
therefore hypothesized that S. aureus
PGN, unlike MDP, resembles the indigest-





















Figure 1. Model for Induction of IL-1b by Staphylococcus aureus
A two-step process leads to IL-1b production. S. aureus is taken up by phagocytosis and is recognized by
Toll-like receptors (TLRs), leading to induction of the NF-kB transcription factor and production of pro-IL-
1b. Wild-type S. aureus O-acetylates its peptidoglycan (PGN), rendering it resistant to lysozyme; conse-
quently, little IL-1b is produced. Mutants lacking the O-acetyltransferase gene, oatA, are digested by lyso-
zyme, leading to activation of the Nlrp3 inflammasome and caspase-1 (Shimada et al., 2010). Caspase-1
processes pro-IL-1b, leading to secretion of the active cytokine. The precise molecular mechanism by
which Nlrp3 is activated remains unresolved. It is possible that the action of lysozyme in the phagosome
generates PGN-derived ligands that activate Nlrp3. Alternatively, it is possible that lysozyme-mediated
lysis of bacteria generates non-PGN ligands that activate Nlrp3. Lastly, it is has previously been proposed
that reactive oxygen intermediates (ROIs) (Dostert et al., 2008) and cell damage resulting from phagoso-
mal rupture are signals that activate Nlrp3 (Hornung et al., 2008).
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Nlrp3. Consistent with this hypothesis,
enzymatic digestion and solubilization of
the PGN preparation rendered it inca-
pable of inducing IL-1b (but had no effect
on induction of another cytokine, TNF-a).
As with other particles that activate
Nlrp3, phagocytosis of the S. aureus
PGN was also required to elicit mature
IL-1b secretion. Also, an inhibitor of lyso-
zyme selectively blocked IL-1b matura-
tion and release without affecting TNF-
a secretion. Based on these observations,
the authors proposed a plausible and
interesting model, in which digestion of
insoluble PGN by lysozyme in the phago-
some is an essential step by which S.
aureus PGN can activate Nlrp3 inflamma-
some in the cytosol (Figure 1).
What relevance do observations with
purified PGN have for infections with live
S. aureus? Interestingly,S. aureusO-acet-
ylates its PGN, rendering it highly resistant
to lysozyme. Accordingly, in the experi-
ments of Shimada et al., wild-type
S. aureus does not appear to induce
much IL-1b (though some must be
induced, given the susceptibility of IL-1b4 Cell Host & Microbe 7, January 21, 2010 ª2knockouts to S. aureus in vivo). The ability
of lysozyme to digest purified S. aureus
PGN appears to result from the methods
used to purify the PGN. However, live
S. aureus can also be rendered suscep-
tible to lysozyme by mutation of its O-ace-
tyltransferase gene, oatA. Consistent
with their model (Figure 1), Shimada et al.
show that infection of macrophages with
DoatA mutants induced considerably
more IL-1b than wild-type S. aureus.
Although the increased induction of IL-1b
by DoatA mutants could be due to libera-
tion of non-PGN ligands (e.g., DNA) from
lysed bacteria, the induction of IL-1b by
DoatA S. aureus was still largely depen-
dent on Nlrp3, reminiscent of the results
with pure PGN and suggesting that the
cytosolic DNA sensor Aim2 was not
a major player. Infection of mice with
DoatAS. aureus resulted in larger inflamed
lesions than infection with wild-type,
despite the presence of fewer mutant
bacteria. Future studies with knockout
mice will be needed to address whether
the in vivo phenotypes of DoatA S. aureus
are due to the activities of Nlrp3 and
lysozyme. The authors do show that the010 Elsevier Inc.lesions caused by DoatA could be elimi-
nated by injection of anti-IL-1b/IL-18 anti-
bodies, implying that resistance to lyso-
zyme is critical for the ability of S. aureus
to evade the inflammasome in vivo.
How exactly does digestion of PGN by
lysozyme trigger Nlrp3? Shimada et al.
did not observe phagosomal disruption
by PGN and noted that zymosan, a yeast
cell wall preparation, induced massive
amounts of ROI without inducing IL-1b.
Thus, the authors do not favor the idea
that ROI or lysosomal disruption is in-
volved and instead propose that lyso-
zyme might liberate PGN-derived ligands
that directly or indirectly induce Nlrp3,
perhaps via entry into the cytosol. Direct
evidence for this model will require further
experimentation and ultimately identifica-
tion of the relevant ligand(s) as well as an
explanation of how the ligand is able
to reach the cytosol. Nevertheless, the
model of Shimada et al. is reminiscent of
other reports in the literature demon-
strating that phagosomal digestion is
linked to activation of cytosolic immune
sensors (Boneca et al., 2007; Charrel-
Dennis et al., 2008; Herskovits et al.,
2007). It is not yet clear whether or
how lysozyme could possibly be involved
in activation of Nlrp3 in response to
substances, such as alum or silica, that
are not substrates for lysozyme. Indeed,
the molecular mechanism of Nlrp3 activa-
tion remains poorly understood.
From the teleological armchair, it is
somewhat puzzling why host cells would
trigger IL-1b production in response to
phagocytosis of a microbe that is suscep-
tible to lysozyme. If IL-1b is a cytokine
that is reserved for responses to patho-
gens, rather than harmless microbes, then
it might make more sense to link inflamma-
some activation to engulfment of lyso-
zyme-resistant material, since it might be
thought that pathogens are more likely to
have evolved mechanisms to become re-
sistant to lysozyme than are nonpatho-
gens. Irrespective of these philosophical
considerations, the report of Underhill and
colleagues provides fascinating insights
into how resistance to lysozyme plays a
significant role in regulating the highly bal-
anced interactionofS.aureuswith itshosts.ACKNOWLEDGMENTS
I thank Sarah McWhirter for discussions. Research
in the R.E.V. laboratory is funded by NIH grants
Cell Host & Microbe
PreviewsAI075039 and AI080749 and by Investigator
Awards from the Burroughs Wellcome Fund and
the Cancer Research Institute.
REFERENCES
Boneca, I.G., Dussurget, O., Cabanes, D., Nahori,
M.A., Sousa, S., Lecuit, M., Psylinakis, E., Bourio-
tis, V., Hugot, J.P., Giovannini, M., et al. (2007).
Proc. Natl. Acad. Sci. USA 104, 997–1002.
Charrel-Dennis, M., Latz, E., Halmen, K.A., Trieu-
Cuot, P., Fitzgerald, K.A., Kasper, D.L., and Golen-
bock, D.T. (2008). Cell Host Microbe 4, 543–554.Dostert, C., Pe´trilli, V., Van Bruggen, R., Steele, C.,
Mossman, B.T., and Tschopp, J. (2008). Science
320, 674–677.
Herskovits, A.A., Auerbuch, V., and Portnoy, D.A.
(2007). PLoS Pathog. 3, e51.
Hornung, V., Bauernfeind, F., Halle, A., Samstad,
E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., and
Latz, E. (2008). Nat. Immunol. 9, 847–856.
Mariathasan, S., Weiss, D.S., Newton, K.,
McBride, J., O’Rourke, K., Roose-Girma, M., Lee,
W.P., Weinrauch, Y., Monack, D.M., and Dixit,
V.M. (2006). Nature 440, 228–232.Cell Host & MicrobeMiller, L.S., Pietras, E.M., Uricchio, L.H., Hirano, K.,
Rao, S., Lin, H., O’Connell, R.M., Iwakura, Y.,
Cheung, A.L., Cheng, G., and Modlin, R.L. (2007).
J. Immunol. 179, 6933–6942.
Mun˜oz-Planillo, R., Franchi, L., Miller, L.S., and
Nu´n˜ez, G. (2009). J. Immunol. 183, 3942–3948.
Shimada, T., Park, B.G., Wolf, A.J., Brikos, C.,
Goodridge, H.S., Becker, C.A., Reyes, C.N.,
Miao, E.A., Aderem, A., Go¨tz, F., et al. (2010).
Cell Host Microbe 7, this issue, 38–49.
Vance, R.E., Isberg, R.R., and Portnoy, D.A. (2009).
Cell Host Microbe 6, 10–21.Hemozoin: Malaria’s ‘‘Built-In’’
Adjuvant and TLR9 AgonistHermann Wagner1,*




The ‘‘built-in’’ adjuvant in a whole-microbe vaccine potentially triggers protective immunity. Coban et al. now
demonstrate that crude blood stage extract of the malaria parasite Plasmodium falciparum drives parasite-
specific immune responses via Hemozoin, a byproduct of heme detoxification, functioning as a TLR9 agonist
and, therefore, as a ‘‘built-in’’ adjuvant.There is compelling evidence that patho-
gens, including parasites that cause
chronic infections, often subvert the power
of protective immunity by harnessing regu-
latory T cells (Tregs). Treg function can be
a double-edged sword. On the one hand,
they contribute to maintenance of self-
tolerance by suppressing autoreactive
T cells. On the other hand, Tregs dampen
protective immunity, thereby favoring
chronic infections (Belkaid et al., 2002; Hi-
saeda et al., 2004).
The innate and adaptive immune system
uses two fundamentally different strategies
to recognize infectious invaders. The first
makes use of a limited number of germ-
line-encoded pattern recognition receptors
(PRRs), such as Toll-like receptors (TLRs),
that recognize—as ligand—unique path-
ogen-associated molecular structures
(PAMPs). The latter, however, uses ran-
domly and somatically generated clonally
expressed receptors (Takeda et al.,2003).
Dendritic cells (DCs) expressing TLRs
pilot both innate and adaptive immunity.Upon TLR-driven activation, DCs produce
proinflammatory and protective cytokines
that contribute to innate immunity. DCs
also couple the identity of the invader’s
antigens with its microbial origin. Piloting
of adaptive immunity largely occurs
through TLR-driven maturation of anti-
gen-presenting DCs (Palm and Medzhi-
tov, 2009). There is also compelling
evidence that ‘‘noninflammatory’’ anti-
gen-presenting DCs favor Treg formation
that, in turn, paralyzes DCs, whereas
highly activated DCs drive the generation
of CD4 and CD8 effector cells. Accord-
ingly, the interplay between DC-activated
T-effector/memory cells and dampening
Tregs determines the efficacy of adaptive
immunity.
People in malaria-endemic regions
gradually acquire protective immunity
against the parasite but only after re-
peated infection. This raises the question
as to whether plasmodium-derived anti-
gens are weakly immunogenic because
of a lack of a ‘‘built-in’’ adjuvant or dueto upregulated Tregs (Walther et al.,
2005). Of note, immune escape of malaria
parasites requires activation of Tregs, at
least in murine model systems (Hisaeda
et al., 2008). In terms of ‘‘built-in’’ adju-
vants, whether and how TLRs contribute
to the induction of protective antimalaria
immunity is not fully understood. In partic-
ular, the role of parasite DNA recognition
by TLR9 has been controversial (Coban
et al., 2005; Jaramillo et al., 2004; Par-
roche et al., 2007).
Because nucleic acid recognition by
TLRs—expressed in the phago-endoso-
mal membrane—have been viewed as
ligand specific, it came as a surprise to
learn that purified malaria pigment hemo-
zoin activates innate immune cells via
TLR9, i.e., functioned as TLR9 ligand (Co-
ban et al., 2005). Hemozoin is a heme poly-
mer produced in malaria as a byproduct of
the heme detoxification system and has
been implicated to activate macrophages
and DCs (Jaramillo et al., 2004). However,
according to Parroche et al., DNase7, January 21, 2010 ª2010 Elsevier Inc. 5
